Company Filing History:
Years Active: 2017
Title: Sylvain Pichard: Innovator in Biomedical Research
Introduction
Sylvain Pichard is a notable inventor based in Leuville sur Orge, France. He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic agents targeting specific pathways in disease processes.
Latest Patents
Pichard holds a patent for an HB-EGF inhibitor derived from the R domain of diphtheria toxin. This innovative ligand recombinant protein inhibits HB-EGF (Heparin-Binding Epidermal Growth Factor like) and is designed for the treatment and diagnosis of diseases associated with the activation of the HB-EGF/EGFR pathway. His work in this area has the potential to impact various medical conditions significantly.
Career Highlights
Sylvain Pichard is affiliated with the Commissariat à L'Énergie Atomique et aux Énergies Alternatives, where he continues to advance his research. His dedication to innovation in the biomedical field is evident through his focused work on therapeutic solutions.
Collaborations
Pichard collaborates with esteemed colleagues, including Daniel Gillet and Benoit Villiers. Their combined expertise enhances the research efforts and contributes to the development of groundbreaking solutions in their field.
Conclusion
Sylvain Pichard's contributions to biomedical research, particularly through his patent on HB-EGF inhibitors, highlight his role as an innovator in the industry. His work promises to advance treatment options for diseases linked to the HB-EGF/EGFR pathway.